Transcranial Static Magnetic Field Stimulation (tSMS) in Amyotrophic Lateral Sclerosis (ALS).

  • STATUS
    Recruiting
  • participants needed
    40
  • sponsor
    Campus Bio-Medico University
Updated on 19 February 2024
antidepressants
excitability
cognitive impairment
epilepsy
riluzole
amyotrophic lateral sclerosis
primary lateral sclerosis
riluzole 50 mg
nervous system
percutaneous endoscopic gastrostomy

Summary

This study aims to evaluate safety and efficacy of tSMS in ALS patients and to obtain preliminary data about the effects of tSMS on cortical excitability.

To this purpose, 40 ALS patients will be recruited and randomized to real or sham tSMS. After 3 months follow-up, they will undergo tSMS, daily for 120 min, at home, for 6 consecutive months.

Clinical status will be tested before, during and after the stimulation period. Moreover, cortical excitability will be tested by transcranial magnetic stimulation (TMS) before and after the stimulation period.

Details
Condition Myelopathy, spinal cord disorders, Amyotrophic Lateral Sclerosis, spinal cord disorders
Age 18-75 years
Treatment tSMS, sham tSMS
Clinical Study IdentifierNCT04393467
SponsorCampus Bio-Medico University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

age between 18 and 75 years
diagnosis of ALS according to revised El Escorial criteria and Awaji-Shima criteria
disease duration < 24 months
ALSFRS-R > 30 at the recruitment
ALSFRS-R decline > 1 in the 3-months period before the intervention
normal respiratory functionality (FVC > 80% and ALSFRS-R items 10,11,12 > 4) at the recruitment
treatment with riluzole 50 mg x 2/die

Exclusion Criteria

inclusion in other clinical trials
presence of tracheotomy or/and PEG (percutaneous endoscopic gastrostomy)
contraindications to magnetic fields exposure
pregnancy or breast-feeding
history of epilepsy or seizures
assumption of drugs acting on central nervous system, except for antidepressive drugs and benzodiazepines
cognitive impairment
lack of informed consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.